nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—NR3C1—Prednisolone—chronic obstructive pulmonary disease	0.313	0.514	CbGbCtD
Cyproterone acetate—NR3C1—Prednisone—chronic obstructive pulmonary disease	0.296	0.486	CbGbCtD
Cyproterone acetate—AR—FOXA1 transcription factor network—SCGB1A1—chronic obstructive pulmonary disease	0.00284	0.0832	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—SFTPD—chronic obstructive pulmonary disease	0.00216	0.063	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—GC—chronic obstructive pulmonary disease	0.00214	0.0625	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.0012	0.0351	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—SERPINA1—chronic obstructive pulmonary disease	0.00116	0.034	CbGpPWpGaD
Cyproterone acetate—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000758	0.00213	CcSEcCtD
Cyproterone acetate—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000756	0.00212	CcSEcCtD
Cyproterone acetate—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000756	0.00212	CcSEcCtD
Cyproterone acetate—Tension—Formoterol—chronic obstructive pulmonary disease	0.000756	0.00212	CcSEcCtD
Cyproterone acetate—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000754	0.00212	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000753	0.00211	CcSEcCtD
Cyproterone acetate—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000749	0.0021	CcSEcCtD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—LEP—chronic obstructive pulmonary disease	0.000746	0.0218	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000743	0.0217	CbGpPWpGaD
Cyproterone acetate—Leukocytosis—Prednisone—chronic obstructive pulmonary disease	0.000738	0.00207	CcSEcCtD
Cyproterone acetate—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000735	0.00206	CcSEcCtD
Cyproterone acetate—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000732	0.00205	CcSEcCtD
Cyproterone acetate—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000727	0.00204	CcSEcCtD
Cyproterone acetate—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000727	0.00204	CcSEcCtD
Cyproterone acetate—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000718	0.00201	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000714	0.002	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000714	0.002	CcSEcCtD
Cyproterone acetate—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000713	0.002	CcSEcCtD
Cyproterone acetate—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000708	0.00198	CcSEcCtD
Cyproterone acetate—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000708	0.00198	CcSEcCtD
Cyproterone acetate—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000694	0.00195	CcSEcCtD
Cyproterone acetate—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000694	0.00195	CcSEcCtD
Cyproterone acetate—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000693	0.00194	CcSEcCtD
Cyproterone acetate—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000685	0.00192	CcSEcCtD
Cyproterone acetate—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000682	0.00191	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000675	0.00189	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000675	0.00189	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000672	0.00189	CcSEcCtD
Cyproterone acetate—Cough—Formoterol—chronic obstructive pulmonary disease	0.000672	0.00188	CcSEcCtD
Cyproterone acetate—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000672	0.00188	CcSEcCtD
Cyproterone acetate—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000668	0.00187	CcSEcCtD
Cyproterone acetate—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000666	0.00187	CcSEcCtD
Cyproterone acetate—Cough—Montelukast—chronic obstructive pulmonary disease	0.000658	0.00185	CcSEcCtD
Cyproterone acetate—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000658	0.00185	CcSEcCtD
Cyproterone acetate—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000656	0.00184	CcSEcCtD
Cyproterone acetate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000656	0.00184	CcSEcCtD
Cyproterone acetate—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000656	0.00184	CcSEcCtD
Cyproterone acetate—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000653	0.00183	CcSEcCtD
Cyproterone acetate—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000653	0.00183	CcSEcCtD
Cyproterone acetate—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000652	0.00183	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000651	0.00183	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000651	0.00183	CcSEcCtD
Cyproterone acetate—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000648	0.00182	CcSEcCtD
Cyproterone acetate—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000648	0.00182	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000639	0.00179	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000638	0.00179	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000637	0.00179	CcSEcCtD
Cyproterone acetate—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000634	0.00178	CcSEcCtD
Cyproterone acetate—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000628	0.00176	CcSEcCtD
Cyproterone acetate—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000628	0.00176	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000626	0.0183	CbGpPWpGaD
Cyproterone acetate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000619	0.00174	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000616	0.00173	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000616	0.00173	CcSEcCtD
Cyproterone acetate—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000616	0.00173	CcSEcCtD
Cyproterone acetate—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000615	0.00173	CcSEcCtD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000615	0.018	CbGpPWpGaD
Cyproterone acetate—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000613	0.00172	CcSEcCtD
Cyproterone acetate—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000613	0.00172	CcSEcCtD
Cyproterone acetate—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000612	0.00172	CcSEcCtD
Cyproterone acetate—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000611	0.00171	CcSEcCtD
Cyproterone acetate—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00061	0.00171	CcSEcCtD
Cyproterone acetate—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00061	0.00171	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000608	0.00171	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000604	0.00169	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000603	0.00169	CcSEcCtD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000601	0.0176	CbGpPWpGaD
Cyproterone acetate—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000598	0.00168	CcSEcCtD
Cyproterone acetate—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000593	0.00166	CcSEcCtD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000593	0.0173	CbGpPWpGaD
Cyproterone acetate—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000587	0.00165	CcSEcCtD
Cyproterone acetate—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000587	0.00165	CcSEcCtD
Cyproterone acetate—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000587	0.00165	CcSEcCtD
Cyproterone acetate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000584	0.00164	CcSEcCtD
Cyproterone acetate—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000584	0.00164	CcSEcCtD
Cyproterone acetate—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000583	0.00164	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000582	0.00163	CcSEcCtD
Cyproterone acetate—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000581	0.00163	CcSEcCtD
Cyproterone acetate—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000579	0.00162	CcSEcCtD
Cyproterone acetate—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000578	0.00162	CcSEcCtD
Cyproterone acetate—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000576	0.00162	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000574	0.00161	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000574	0.00161	CcSEcCtD
Cyproterone acetate—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000566	0.00159	CcSEcCtD
Cyproterone acetate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000565	0.00158	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—HDAC2—chronic obstructive pulmonary disease	0.000561	0.0164	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00056	0.00157	CcSEcCtD
Cyproterone acetate—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00056	0.00157	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	0.000556	0.0162	CbGpPWpGaD
Cyproterone acetate—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000554	0.00156	CcSEcCtD
Cyproterone acetate—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000553	0.00155	CcSEcCtD
Cyproterone acetate—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000553	0.00155	CcSEcCtD
Cyproterone acetate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000551	0.00155	CcSEcCtD
Cyproterone acetate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000546	0.00153	CcSEcCtD
Cyproterone acetate—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000545	0.00153	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000542	0.00152	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000542	0.00152	CcSEcCtD
Cyproterone acetate—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000542	0.00152	CcSEcCtD
Cyproterone acetate—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000542	0.00152	CcSEcCtD
Cyproterone acetate—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000542	0.00152	CcSEcCtD
Cyproterone acetate—CYP19A1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00054	0.0158	CbGpPWpGaD
Cyproterone acetate—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000537	0.00151	CcSEcCtD
Cyproterone acetate—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000537	0.00151	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000531	0.00149	CcSEcCtD
Cyproterone acetate—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000531	0.00149	CcSEcCtD
Cyproterone acetate—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000529	0.00148	CcSEcCtD
Cyproterone acetate—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000526	0.00148	CcSEcCtD
Cyproterone acetate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000525	0.00147	CcSEcCtD
Cyproterone acetate—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000523	0.00147	CcSEcCtD
Cyproterone acetate—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000522	0.00147	CcSEcCtD
Cyproterone acetate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000521	0.00146	CcSEcCtD
Cyproterone acetate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00052	0.00146	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000518	0.00145	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000518	0.00145	CcSEcCtD
Cyproterone acetate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000517	0.00145	CcSEcCtD
Cyproterone acetate—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000516	0.00145	CcSEcCtD
Cyproterone acetate—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000516	0.00145	CcSEcCtD
Cyproterone acetate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000515	0.00144	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000514	0.00144	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000514	0.00144	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000512	0.00144	CcSEcCtD
Cyproterone acetate—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000512	0.00143	CcSEcCtD
Cyproterone acetate—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000507	0.00142	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL13—chronic obstructive pulmonary disease	0.000506	0.0148	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000503	0.00141	CcSEcCtD
Cyproterone acetate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000499	0.0014	CcSEcCtD
Cyproterone acetate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000499	0.0014	CcSEcCtD
Cyproterone acetate—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000497	0.00139	CcSEcCtD
Cyproterone acetate—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000497	0.00139	CcSEcCtD
Cyproterone acetate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000497	0.00139	CcSEcCtD
Cyproterone acetate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000497	0.00139	CcSEcCtD
Cyproterone acetate—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000495	0.00139	CcSEcCtD
Cyproterone acetate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000495	0.00139	CcSEcCtD
Cyproterone acetate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000491	0.00138	CcSEcCtD
Cyproterone acetate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00049	0.00138	CcSEcCtD
Cyproterone acetate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00049	0.00138	CcSEcCtD
Cyproterone acetate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000489	0.00137	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000489	0.00137	CcSEcCtD
Cyproterone acetate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000488	0.00137	CcSEcCtD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000487	0.0142	CbGpPWpGaD
Cyproterone acetate—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000487	0.00136	CcSEcCtD
Cyproterone acetate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000487	0.00136	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000485	0.00136	CcSEcCtD
Cyproterone acetate—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000481	0.00135	CcSEcCtD
Cyproterone acetate—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000479	0.00134	CcSEcCtD
Cyproterone acetate—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000477	0.00134	CcSEcCtD
Cyproterone acetate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000471	0.00132	CcSEcCtD
Cyproterone acetate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000469	0.00132	CcSEcCtD
Cyproterone acetate—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000469	0.00132	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000463	0.0013	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000463	0.0013	CcSEcCtD
Cyproterone acetate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000462	0.0013	CcSEcCtD
Cyproterone acetate—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000462	0.00129	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000453	0.00127	CcSEcCtD
Cyproterone acetate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000451	0.00126	CcSEcCtD
Cyproterone acetate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000451	0.00126	CcSEcCtD
Cyproterone acetate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000445	0.00125	CcSEcCtD
Cyproterone acetate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000445	0.00125	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000444	0.00124	CcSEcCtD
Cyproterone acetate—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000444	0.00124	CcSEcCtD
Cyproterone acetate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000442	0.00124	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000437	0.00123	CcSEcCtD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000437	0.0128	CbGpPWpGaD
Cyproterone acetate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000435	0.00122	CcSEcCtD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000431	0.0126	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00043	0.00121	CcSEcCtD
Cyproterone acetate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00043	0.00121	CcSEcCtD
Cyproterone acetate—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000426	0.0012	CcSEcCtD
Cyproterone acetate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000426	0.00119	CcSEcCtD
Cyproterone acetate—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000424	0.00119	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	0.000422	0.0123	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000421	0.00118	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	0.000421	0.0123	CbGpPWpGaD
Cyproterone acetate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00042	0.00118	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—chronic obstructive pulmonary disease	0.000417	0.0122	CbGpPWpGaD
Cyproterone acetate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000416	0.00117	CcSEcCtD
Cyproterone acetate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.00117	CcSEcCtD
Cyproterone acetate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000407	0.00114	CcSEcCtD
Cyproterone acetate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000406	0.00114	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000401	0.00112	CcSEcCtD
Cyproterone acetate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.0004	0.00112	CcSEcCtD
Cyproterone acetate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.0004	0.00112	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000398	0.0117	CbGpPWpGaD
Cyproterone acetate—Rash—Formoterol—chronic obstructive pulmonary disease	0.000396	0.00111	CcSEcCtD
Cyproterone acetate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000396	0.00111	CcSEcCtD
Cyproterone acetate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000396	0.00111	CcSEcCtD
Cyproterone acetate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000396	0.00111	CcSEcCtD
Cyproterone acetate—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000396	0.00111	CcSEcCtD
Cyproterone acetate—Headache—Formoterol—chronic obstructive pulmonary disease	0.000394	0.0011	CcSEcCtD
Cyproterone acetate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000394	0.0011	CcSEcCtD
Cyproterone acetate—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000393	0.0011	CcSEcCtD
Cyproterone acetate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000392	0.0011	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000392	0.0011	CcSEcCtD
Cyproterone acetate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000391	0.0011	CcSEcCtD
Cyproterone acetate—Rash—Montelukast—chronic obstructive pulmonary disease	0.000388	0.00109	CcSEcCtD
Cyproterone acetate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000388	0.00109	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000387	0.00109	CcSEcCtD
Cyproterone acetate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—chronic obstructive pulmonary disease	0.000386	0.0113	CbGpPWpGaD
Cyproterone acetate—Headache—Montelukast—chronic obstructive pulmonary disease	0.000386	0.00108	CcSEcCtD
Cyproterone acetate—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000382	0.00107	CcSEcCtD
Cyproterone acetate—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.00038	0.00107	CcSEcCtD
Cyproterone acetate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000377	0.00106	CcSEcCtD
Cyproterone acetate—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000376	0.00105	CcSEcCtD
Cyproterone acetate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000374	0.00105	CcSEcCtD
Cyproterone acetate—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000374	0.00105	CcSEcCtD
Cyproterone acetate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000374	0.00105	CcSEcCtD
Cyproterone acetate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000373	0.00105	CcSEcCtD
Cyproterone acetate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000373	0.00105	CcSEcCtD
Cyproterone acetate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000372	0.00104	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000366	0.00103	CcSEcCtD
Cyproterone acetate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000366	0.00103	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000363	0.0106	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.00036	0.0105	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	0.000359	0.0105	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000354	0.0104	CbGpPWpGaD
Cyproterone acetate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000352	0.000989	CcSEcCtD
Cyproterone acetate—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000351	0.000984	CcSEcCtD
Cyproterone acetate—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.00035	0.000981	CcSEcCtD
Cyproterone acetate—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000348	0.000976	CcSEcCtD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—TNF—chronic obstructive pulmonary disease	0.000345	0.0101	CbGpPWpGaD
Cyproterone acetate—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000342	0.000959	CcSEcCtD
Cyproterone acetate—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00034	0.000955	CcSEcCtD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	0.000335	0.00981	CbGpPWpGaD
Cyproterone acetate—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000335	0.000939	CcSEcCtD
Cyproterone acetate—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000332	0.000932	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000329	0.000923	CcSEcCtD
Cyproterone acetate—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000325	0.000912	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	0.000319	0.00934	CbGpPWpGaD
Cyproterone acetate—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000316	0.000886	CcSEcCtD
Cyproterone acetate—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000314	0.000882	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000311	0.00911	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000308	0.009	CbGpPWpGaD
Cyproterone acetate—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000308	0.000863	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	0.000305	0.00893	CbGpPWpGaD
Cyproterone acetate—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000305	0.000855	CcSEcCtD
Cyproterone acetate—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000303	0.00085	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000302	0.00884	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	0.0003	0.00876	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.00029	0.00848	CbGpPWpGaD
Cyproterone acetate—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000281	0.000789	CcSEcCtD
Cyproterone acetate—NR3C1—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	0.000281	0.00822	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00028	0.000787	CcSEcCtD
Cyproterone acetate—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00028	0.000786	CcSEcCtD
Cyproterone acetate—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000278	0.000781	CcSEcCtD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—IL6—chronic obstructive pulmonary disease	0.000278	0.00814	CbGpPWpGaD
Cyproterone acetate—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000273	0.000766	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000273	0.00798	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	0.000272	0.00795	CbGpPWpGaD
Cyproterone acetate—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000272	0.000762	CcSEcCtD
Cyproterone acetate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00027	0.000758	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MMP1—chronic obstructive pulmonary disease	0.000269	0.00787	CbGpPWpGaD
Cyproterone acetate—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000266	0.000747	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000259	0.00757	CbGpPWpGaD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000256	0.000719	CcSEcCtD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000255	0.00746	CbGpPWpGaD
Cyproterone acetate—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000255	0.000715	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000251	0.000703	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000249	0.00729	CbGpPWpGaD
Cyproterone acetate—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000247	0.000694	CcSEcCtD
Cyproterone acetate—Shock—Prednisone—chronic obstructive pulmonary disease	0.000243	0.000682	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000243	0.00068	CcSEcCtD
Cyproterone acetate—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000241	0.000677	CcSEcCtD
Cyproterone acetate—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00024	0.000674	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000239	0.000671	CcSEcCtD
Cyproterone acetate—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000236	0.000661	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—chronic obstructive pulmonary disease	0.000233	0.0068	CbGpPWpGaD
Cyproterone acetate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.000631	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000221	0.00645	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000219	0.0064	CbGpPWpGaD
Cyproterone acetate—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000218	0.000611	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.000218	0.00636	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000216	0.00631	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000215	0.000603	CcSEcCtD
Cyproterone acetate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000215	0.000602	CcSEcCtD
Cyproterone acetate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000214	0.000601	CcSEcCtD
Cyproterone acetate—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000213	0.000598	CcSEcCtD
Cyproterone acetate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000213	0.000598	CcSEcCtD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000213	0.00623	CbGpPWpGaD
Cyproterone acetate—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000211	0.000593	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—chronic obstructive pulmonary disease	0.00021	0.00615	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	0.000206	0.00603	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000204	0.000572	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000202	0.000567	CcSEcCtD
Cyproterone acetate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000202	0.000567	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000198	0.0058	CbGpPWpGaD
Cyproterone acetate—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000196	0.000551	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	0.000196	0.00574	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000196	0.00572	CbGpPWpGaD
Cyproterone acetate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000195	0.000548	CcSEcCtD
Cyproterone acetate—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000195	0.000548	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000189	0.00553	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000188	0.0055	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.000187	0.00547	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000185	0.00542	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000511	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—LEP—chronic obstructive pulmonary disease	0.00018	0.00526	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	0.000178	0.00519	CbGpPWpGaD
Cyproterone acetate—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000498	CcSEcCtD
Cyproterone acetate—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000491	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—chronic obstructive pulmonary disease	0.000173	0.00506	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000169	0.000475	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000167	0.00489	CbGpPWpGaD
Cyproterone acetate—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000459	CcSEcCtD
Cyproterone acetate—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000441	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—EGFR—chronic obstructive pulmonary disease	0.000156	0.00456	CbGpPWpGaD
Cyproterone acetate—Rash—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000437	CcSEcCtD
Cyproterone acetate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000437	CcSEcCtD
Cyproterone acetate—Headache—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000435	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000151	0.00442	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—TGFB1—chronic obstructive pulmonary disease	0.00015	0.00438	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000149	0.00436	CbGpPWpGaD
Cyproterone acetate—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000412	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	0.000146	0.00428	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	0.000141	0.00413	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000136	0.00399	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000131	0.00382	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	0.00012	0.00352	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000114	0.00332	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000113	0.00331	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000111	0.00324	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	0.00011	0.00322	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000108	0.00315	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	0.000106	0.0031	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000103	0.00302	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000102	0.00299	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.0001	0.00293	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	9.94e-05	0.00291	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	9.92e-05	0.0029	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	9.78e-05	0.00286	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GC—chronic obstructive pulmonary disease	9.75e-05	0.00285	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	9.72e-05	0.00284	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	9.49e-05	0.00277	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	9.41e-05	0.00275	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.06e-05	0.00265	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	8.92e-05	0.00261	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	8.8e-05	0.00257	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	8.64e-05	0.00253	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	8.58e-05	0.00251	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	8.47e-05	0.00248	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	8.4e-05	0.00246	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TNF—chronic obstructive pulmonary disease	8.33e-05	0.00244	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	8.07e-05	0.00236	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	7.66e-05	0.00224	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	7.39e-05	0.00216	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.22e-05	0.00211	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	7.2e-05	0.0021	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—CTGF—chronic obstructive pulmonary disease	7.18e-05	0.0021	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	7.11e-05	0.00208	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	6.8e-05	0.00199	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IL6—chronic obstructive pulmonary disease	6.72e-05	0.00197	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—HDAC2—chronic obstructive pulmonary disease	6.69e-05	0.00196	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	5.81e-05	0.0017	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—CTGF—chronic obstructive pulmonary disease	5.45e-05	0.00159	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.33e-05	0.00156	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.26e-05	0.00154	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	5.16e-05	0.00151	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	5.08e-05	0.00148	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.91e-05	0.00144	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.8e-05	0.0014	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.43e-05	0.00129	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.69e-05	0.00108	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.64e-05	0.00106	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.39e-05	0.000992	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	3.27e-05	0.000957	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.22e-05	0.00094	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.48e-05	0.000726	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALB—chronic obstructive pulmonary disease	2.19e-05	0.000639	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.09e-05	0.000612	CbGpPWpGaD
